| scholarly article | Q13442814 |
| P2093 | author name string | Khalid Shah | |
| Jose-Luiz Figueiredo | |||
| Shawn Hingtgen | |||
| Timo M Kauer | |||
| P2860 | cites work | APO2 ligand: a novel lethal weapon against malignant glioma? | Q28272697 |
| A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. | Q39744489 | ||
| Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. | Q39853842 | ||
| Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. | Q39897760 | ||
| Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model | Q39988659 | ||
| Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR | Q40619097 | ||
| Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model | Q42573981 | ||
| Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis. | Q45798961 | ||
| Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas | Q45870836 | ||
| Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection | Q46065962 | ||
| Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand | Q46324484 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. | Q46771343 | ||
| Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold | Q48568413 | ||
| Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. | Q50524244 | ||
| The risk of putting something where it does not belong: mesenchymal stem cells produce masses in the brain | Q83656011 | ||
| Death receptors: signaling and modulation | Q28280897 | ||
| CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels | Q28292053 | ||
| Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells | Q30476168 | ||
| Advances in brain tumor surgery | Q31134396 | ||
| Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy | Q33465104 | ||
| mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells | Q34097241 | ||
| The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue | Q34154476 | ||
| A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR. | Q34312127 | ||
| Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand | Q34551591 | ||
| Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography | Q34657611 | ||
| Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts | Q35175677 | ||
| Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. | Q35812718 | ||
| Mesenchymal stem cells engineered for cancer therapy | Q36092724 | ||
| Chemotherapy delivery issues in central nervous system malignancy: a reality check. | Q36835363 | ||
| Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles | Q36901346 | ||
| Biomimetic material systems for neural progenitor cell-based therapy | Q36991941 | ||
| Cell delivery mechanisms for tissue repair | Q37121094 | ||
| Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare | Q37122166 | ||
| Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy | Q37140126 | ||
| Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors | Q37346039 | ||
| Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide | Q37356520 | ||
| Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors | Q37372468 | ||
| Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors | Q37447217 | ||
| Glioblastoma multiforme: a review of where we have been and where we are going | Q37530934 | ||
| Biomaterials for promoting brain protection, repair and regeneration. | Q37572357 | ||
| Induced pluripotent stem cells: a new revolution for clinical neurology? | Q37857439 | ||
| Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). | Q38673432 | ||
| Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy | Q39245228 | ||
| Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions | Q39569903 | ||
| A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models | Q39630653 | ||
| Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Glioma Therapy | Q39644411 | ||
| Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro | Q39681548 | ||
| Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. | Q39725116 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 197-204 | |
| P577 | publication date | 2011-12-25 | |
| P1433 | published in | Nature Neuroscience | Q1535359 |
| P1476 | title | Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas | |
| P478 | volume | 15 |
| Q38635798 | A 3D-Engineered Conformal Implant Releases DNA Nanocomplexs for Eradicating the Postsurgery Residual Glioblastoma |
| Q44548491 | A microgel construction kit for bioorthogonal encapsulation and pH-controlled release of living cells |
| Q38308868 | Advances in cell encapsulation technology and its application in drug delivery |
| Q38227489 | Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy |
| Q58223823 | Application of Millifluidics to Encapsulate and Support Viable Human Mesenchymal Stem Cells in a Polysaccharide Hydrogel |
| Q36176880 | B(12)-mediated, long wavelength photopolymerization of hydrogels. |
| Q30724766 | BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis |
| Q33753135 | Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors |
| Q30614247 | Biopolymer implants enhance the efficacy of adoptive T-cell therapy. |
| Q90405817 | Cancer in a dish: progress using stem cells as a platform for cancer research |
| Q38960128 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors |
| Q58724855 | Concise Review: Neural Stem Cell-Mediated Targeted Cancer Therapies |
| Q27327216 | Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography |
| Q89936443 | Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma |
| Q83288373 | Drug delivery: Encapsulation improves therapeutic stem cell action |
| Q56992592 | Ein Mikrogelbaukasten für die bioorthogonale Verkapselung und pH-gesteuerte Freisetzung von lebenden Zellen |
| Q30843565 | Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma |
| Q47214779 | Encapsulated Optically Responsive Cell Systems: Toward Smart Implants in Biomedicine. |
| Q38090923 | Encapsulated stem cells for cancer therapy |
| Q38944271 | Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy. |
| Q34444939 | Engineering toxin-resistant therapeutic stem cells to treat brain tumors |
| Q92349932 | Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer |
| Q64105995 | Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma |
| Q36684365 | Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer. |
| Q67201058 | Gene editing for immune cell therapies |
| Q94660275 | Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients |
| Q39310030 | Generation and manipulation of hydrogel microcapsules by droplet-based microfluidics for mammalian cell culture |
| Q38790593 | Genetic engineering of platelets to neutralize circulating tumor cells |
| Q90449437 | Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells |
| Q90608879 | Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds |
| Q57297372 | In situ administration of cytokine combinations induces tumor regression in mice |
| Q37022290 | Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo |
| Q57640952 | Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection |
| Q64277474 | Magnetic ternary nanohybrids for nonviral gene delivery of stem cells and applications on cancer therapy |
| Q55456721 | Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound. |
| Q34647951 | Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas |
| Q38715077 | Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas |
| Q57372236 | Microfluidic-Based Synthesis of Hydrogel Particles for Cell Microencapsulation and Cell-Based Drug Delivery |
| Q26999345 | Molecular mechanism underlying lymphatic metastasis in pancreatic cancer |
| Q37473651 | Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery |
| Q33704489 | Neural stem cell therapy for cancer |
| Q92099101 | Oncolytic viruses: overcoming translational challenges |
| Q90419003 | Patient-Derived Glioma Models: From Patients to Dish to Animals |
| Q38764607 | Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model. |
| Q36543537 | Real-time multi-modality imaging of glioblastoma tumor resection and recurrence. |
| Q89976335 | Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications |
| Q38133954 | Regenerative therapies for central nervous system diseases: a biomaterials approach |
| Q33620254 | Regulation of gap junction channels by infectious agents and inflammation in the CNS. |
| Q58803096 | Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors |
| Q26775038 | Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions |
| Q38245163 | Stem cell-based therapies for cancer treatment: separating hope from hype |
| Q38855638 | Stem cell-based therapies for tumors in the brain: are we there yet? |
| Q47142453 | Stem cells in cancer therapy: opportunities and challenges |
| Q42218017 | Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. |
| Q90361854 | Stem cells: a promising candidate to treat neurological disorders |
| Q37707063 | Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy |
| Q48225985 | Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection. |
| Q37433463 | TRAIL on trial: preclinical advances in cancer therapy |
| Q54438434 | Targeting Tumor Hypoxia Using Nanoparticle-engineered CXCR4-overexpressing Adipose-derived Stem Cells. |
| Q35974503 | Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells |
| Q35153149 | Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors |
| Q37109638 | The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells |
| Q92003487 | Theranostic OCT microneedle for fast ultrahigh-resolution deep-brain imaging and efficient laser ablation in vivo |
| Q49936618 | Therapeutic Neural Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies |
| Q38213836 | Therapeutic cell carriers: a potential road to cure glioma |
| Q39198277 | Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors |
| Q36339837 | Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects. |
| Q27333831 | Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma. |
| Q50083504 | Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas. |
| Q48329121 | Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. |
| Q38730790 | Use of genetically engineered stem cells for glioma therapy |
| Q52872887 | Visualization of real-time degradation of pH-responsive polyglycerol nanogels via atomic force microscopy. |
| Q41920847 | microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis |
Search more.